Anne Campbell

Anne Campbell has a diverse work experience in the field of scientific research. Anne is currently working as a Scientist I at Vor Biopharma since July 2022. Prior to this, they served as a Principal Associate Scientist at Vor Biopharma from February 2021 to July 2022.

Before joining Vor Biopharma, Anne was an Associate Scientist at Celgene from September 2018 to February 2021. During their time there, they were involved in the development of secondary functional assays, including a robust assay of RNA degradation and an RNA-based assay to screen for off-target hits.

Anne also worked as an Associate Scientist II at Biogen from June 2016 to August 2018. Anne'sresponsibilities included the development of transcriptomic assays, identification of predictive genes for transcription factor engagement, and the development of a high-throughput qPCR-based assay for compound screening.

Prior to their industry experience, Anne worked as a Research Assistant II at MDI Biological Laboratory from September 2012 to May 2016.

Anne's work experience began with their role as a Student at the University of Maine from 2008 to 2012. Anne'sresearch thesis and Honors College Capstone project focused on a comparative analysis of limb regeneration using gene expression data from Danio rerio and Ambystoma mexicanum. Anne'sresearch involved bioinformatics techniques and the discovery of potentially interesting genes related to regenerative mechanisms.

Overall, Anne Campbell has gained valuable experience in various scientific research roles with a focus on assay development, gene expression analysis, and molecular mechanisms.

Anne Campbell completed their Bachelor's degree in Chemistry & Biochemistry dual degree at the University of Maine, Orono. Anne attended the university from 2008 to 2012 and was a member of the Honors College.